Immediate Effect of Kangaroo Position in Electromyographic Activity and Microcirculation of Newborn Preterm
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02849665|
Recruitment Status : Unknown
Verified August 2017 by Kaísa Trovão Diniz, Professor Fernando Figueira Integral Medicine Institute.
Recruitment status was: Recruiting
First Posted : July 29, 2016
Last Update Posted : August 16, 2017
|Condition or disease||Intervention/treatment||Phase|
|Child Development||Other: Kangaroo Position||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||50 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Primary Purpose:||Basic Science|
|Official Title:||Immediate Effect of Kangaroo Position in Electromyographic Activity and Microcirculation of Newborn Preterm: A Randomized Clinical Trial.|
|Study Start Date :||October 1, 2016|
|Estimated Primary Completion Date :||August 2017|
|Estimated Study Completion Date :||August 2017|
Experimental: Kangaroo Position
The newborn remains in a vertical position, with limbs flexed, dressed in light clothes, maintaining skin-to-skin contact and the face on the adult's thorax.
Other: Kangaroo Position
No Intervention: Not Kangaroo Position
The newborns will be not placed in the position Kangaroo.
- Electromyographic activity [ Time Frame: 15 minutes ]Measure of the changes in electric potential of muscle.
- Tissue oxygen saturation - SO2 [ Time Frame: 5 minutes ]
- Relative oxygenated haemoglobin concentration - oxyHb [ Time Frame: 5 minutes ]
- Relative deoxygenated haemoglobin concentration - deoxyHb [ Time Frame: 5 minutes ]
- Relative total haemoglobin concentration -totalHb [ Time Frame: 5 minutes ]
- Temperature [ Time Frame: 5 minutes ]Tissue temperature
- Blood flow [ Time Frame: 5 minutes ]A quantity proportional to the product of the average speed of the blood cells and their number concentration.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02849665
|Contact: Kaísa T. Diniz, PhD student||+55 81 email@example.com|
|Contact: José E. Cabral Filho, PhD||+ 55 81 22122 firstname.lastname@example.org|
|Recife, Pernambuco, Brazil, 50070-550|
|Contact: Geisy Maria Souza Lima, MD 55 81 21224125 email@example.com|
|Study Director:||José E. Cabral Filho, PhD||Instituto de Medicina Integral Prof. Fernando Figueira - IMIP|
|Study Chair:||Rafael M. Miranda, PhD student||Instituto de Medicina Integral Prof. Fernando Figueira - IMIP|
|Study Chair:||João G. Bezerra alves, PhD||Instituto de Medicina Integral Prof. Fernando Figueira - IMIP|
|Study Chair:||Geraldine F. Clough, PhD||University of Southampton - Academic Unit of Human Development and Health|
|Principal Investigator:||Kaísa T. Diniz, PhD student||Instituto de Medicina Integral Prof. Fernando Figueira - IMIP|